Status:
COMPLETED
A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Irritable Bowel Syndrome
Eligibility:
MALE
20-64 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to explore and examine endpoints that allow evaluation of the "clinically significant improvements, focusing on the patient's chief complaint and the severity of major IBS...
Eligibility Criteria
Inclusion
- Patients meeting the Rome III Diagnostic Criteria
- Loose (mushy) or watery stools within the last 3 months
Exclusion
- Patients having hyperthyroidism or hypothyroidism
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00918411
Start Date
June 1 2009
End Date
December 1 2009
Last Update
October 12 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hokkaido, Japan
2
Kansai, Japan
3
Kantou, Japan
4
Kyusyu, Japan